Company Analysis
Sign in

SpyGlass Pharma, Inc. (SGP)

Nasdaq: SGP · Surgical & Medical Instruments & Apparatus · Aliso Viejo, CA · filing with the SEC since 2019
Full chart Alerts Compare
Grade5.8
◀ Past 5.8● Present 4.8▶ Future 7.2
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

14 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to SpyGlass Pharma, Inc.’s names, not what it holds today.

Patents granted
14
14 utility, 1976 to Dec 31, 2025
Granted in 2025
3
Against 3 in 2024 and 6 in 2023
Applications published
22
3 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology14
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
SpyGlass Pharma, Inc. its own name
named as the applicant on its applications, in US
0 granted
19 published
SpyGlass Pharma, Inc. its own name
US, as the owner printed on each patent
14 granted
3 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 16, 202512,496,187Systems to affix devices to intraocular lens assemblies and related methodsMedical technologySpyGlass Pharma, Inc.
Dec 2, 202512,485,002Stabilized intraocular drug delivery systems and methods of useMedical technologySpyGlass Pharma, Inc.
Apr 29, 202512,285,357Intraocular drug delivery systems and methods of useMedical technologySpyGlass Pharma, Inc.
Dec 10, 202412,161,548Intraocular drug delivery platformMedical technologySpyGlass Pharma, Inc.
Feb 20, 202411,903,874Ophthalmic implant system for drug deliveryMedical technologySpyGlass Pharma, Inc.
Jan 30, 202411,883,277IOL with drug delivery devices and uninterrupted PCO barrier edgeMedical technologySpyGlass Pharma, Inc.
Nov 14, 202311,813,159Intraocular drug delivery platformMedical technologySpyGlass Pharma, Inc.
Nov 7, 202311,806,227Sulcus implants and methods of using the sameMedical technologySpyGlass Pharma, Inc.
Oct 10, 202311,779,457Systems to affix devices to intraocular lens assemblies and related methodsMedical technologySpyGlass Pharma, Inc.
Oct 3, 202311,771,592Stabilized intraocular drug delivery systems and methods of useMedical technologySpyGlass Pharma, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Oct 9, 20252025/0312191INTRAOCULAR DRUG DELIVERY DEVICES, SYSTEMS, AND METHODS OF USEPharmaceuticalsSpyGlass Pharma, Inc.
May 15, 20252025/0152414INTRAOCULAR DRUG DELIVERY SYSTEMS AND METHODS OF USEMedical technologySpyGlass Pharma, Inc.
May 8, 20252025/0143869INTRAOCULAR DRUG DELIVERY PLATFORMMedical technologySpyGlass Pharma, Inc.
Nov 14, 20242024/0374420OPHTHALMIC IMPLANT SYSTEM FOR DRUG DELIVERYMedical technologySpyGlass Pharma, Inc.
Apr 4, 20242024/0108455SULCUS IMPLANTS AND METHODS OF USING THE SAMEMedical technologySpyGlass Pharma, Inc.
Mar 7, 20242024/0074848INTRAOCULAR DRUG DELIVERY PLATFORMMedical technologySpyGlass Pharma, Inc. · patent 12,161,548 granted from it
Jan 25, 20242024/0024158INTRAOCULAR DRUG DELIVERY SYSTEMS AND METHODS OF USEMedical technologySpyGlass Pharma, Inc. · patent 12,285,357 granted from it
Jan 25, 20242024/0024093INTRAOCULAR DRUG DELIVERY SYSTEMS AND METHODS OF USEMedical technologySpyGlass Pharma, Inc.
Jan 25, 20242024/0024092INTRAOCULAR DRUG DELIVERY SYSTEMS AND METHODS OF USEMedical technologySpyGlass Pharma, Inc. · patent 12,193,972 granted from it
Dec 21, 20232023/0404801STABILIZED INTRAOCULAR DRUG DELIVERY SYSTEMS AND METHODS OF USEMedical technologySpyGlass Pharma, Inc. · patent 12,485,002 granted from it
What it applied for, 2024 to 2025: Medical technology 8 · Pharmaceuticals 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton SGP · research, not advice